"We look forward to the upcoming 'phase III' trial to demonstrate large-scale safety and efficacy data for a vaccine that is greatly needed in this region."
UTinto uthe "silangazelele ukuhlolwa okuzayo 'kwesigaba sesithathu' ukukhombisa imininingwane emikhulu yokuphepha nokusebenza komuthi okudingeka kakhulu."